However, given the limited understanding of TREM2’s function across ALS stages and the increasing evidence highlighting the complexity of microglial phenotypes beyond the conventional M1/M2 paradigm [56], further analyses are required to draw definitive conclusions. This evidence concerns the gene TREM2 and amyotrophic lateral sclerosis.